AbbVie's SWOT analysis: biopharma giant navigates post-Humira landscape
AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company with a market capitalization of $311.86 billion, has been at the forefront of the industry with its diverse portfolio of pharmaceuticals ...
Outsourcing-pharma5 天
The largest pharma acquisitions of 2024
From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.